Rab GTPase Switch: How Cells Label Every Vesicle's Destination

What a Rab GTPase Is and Where It Works

Rab (Ras-related in brain) proteins are small, monomeric GTPases of roughly 200 amino acids and ~20-25 kDa. Humans encode about 60-70 Rab genes, making Rabs by far the largest family within the Ras superfamily; yeast get by with only 11 (the Ypt/Sec4 proteins). Each Rab localizes to the cytoplasmic face of a defined compartment, so the set of active Rabs on a membrane defines that membrane's identity.

• Rab1 — ER-to-Golgi transport
• Rab2 — Golgi and ER-Golgi intermediate compartment
• Rab5 — early endosomes and endocytosis
• Rab7 — late endosomes and lysosomes
• Rab11 — recycling endosomes
• Rab27 — secretory-granule and melanosome exocytosis

Because Rabs sit at every node of the endomembrane system — ER, Golgi, endosomes, lysosomes, the plasma membrane, and secretory vesicles — they collectively supervise budding, motility, tethering, and fusion. The switch itself is universal; what changes is which effectors a given Rab reads out, and thus which trafficking step it commands.

The Switch, Step by Step

The Rab cycle is a chemically simple loop with tight spatial control. Each turn does mechanical work by coupling nucleotide state to a protein conformational change.

• 1. Prenylation and delivery. A newly made Rab is bound by REP (Rab escort protein), which presents it to Rab geranylgeranyltransferase (RabGGTase / GGTase-II). One or two C20 geranylgeranyl lipids are attached to C-terminal cysteines (motifs like -CC, -CXC, -CCXX), giving the Rab a membrane anchor.
• 2. Activation. A membrane-localized GEF pries open the nucleotide pocket and ejects GDP. Because cytosolic GTP outnumbers GDP roughly 10:1, GTP loads and the switch flips ON.
• 3. Effector engagement. GTP binding reorders the switch I and switch II loops via a magnesium ion and the gamma-phosphate; this creates the surface that active-state effectors recognize.
• 4. Inactivation. A GAP supplies catalytic arginine and glutamine residues that accelerate GTP hydrolysis by up to 10^5-fold. Switch regions relax; effectors let go.
• 5. Extraction and recycling. GDI caps the prenyl tail and pulls the GDP-Rab back into the cytosol, ready for redelivery to the correct membrane by a GDF.

Key Molecules and Concrete Numbers

The switch is governed by the nucleotide chemistry of the G-domain. The buried magnesium ion and the P-loop (phosphate-binding loop, consensus GxxxxGK[S/T]) coordinate the phosphates; switch I and switch II sense whether the gamma-phosphate is present.

• Intrinsic hydrolysis is slow: uncatalyzed k_cat is on the order of ~10^-4 to 10^-3 per second (minutes to hours), which is why GAPs are needed to make timely OFF decisions.
• GAP acceleration: up to ~10^5-fold, dropping the switch-off time to seconds.
• Nucleotide affinity: Rabs bind GDP/GTP with picomolar-to-nanomolar affinity, so GEFs are required to force GDP release.
• Lipid anchor: geranylgeranyl is a 20-carbon (C20) isoprenoid; two anchors give near-irreversible membrane binding until GDI extracts them.

Concrete example — the Rab5 module. On early endosomes, GTP-Rab5 recruits EEA1 (a ~1,400-residue tethering coiled-coil), Rabaptin-5, and the Vps34 PI3-kinase that makes PtdIns(3)P. Rabaptin-5 binds the Rab5 GEF Rabex-5, creating a positive-feedback loop that concentrates active Rab5 into a sharp membrane domain — a self-amplifying address label.

How Rab Switching Is Studied and Observed

Much of what we know comes from locking the switch in one state and watching the consequences.

• Constitutively active mutants (Q→L): mutating the catalytic glutamine (e.g., Rab5 Q79L) cripples GTP hydrolysis, freezing the switch ON and producing giant, swollen endosomes visible by light microscopy.
• Dominant-negative mutants (S/T→N): mutating the P-loop serine/threonine (e.g., Rab5 S34N) traps the nucleotide-empty or GDP form, blocking the pathway.
• Structural biology: the first Rab crystal structures were of yeast Sec4p in GDP and GTP states, pinpointing switch I and switch II; disorder of switch I in the GDP form explains its high GDP off-rate.
• Fluorescence and biochemistry: GTP-locked analogs (GppNHp, GTPgammaS), mant-nucleotide exchange assays, and GFP-Rab live imaging quantify on/off kinetics and membrane residence.
• Genetics: yeast ypt1 and sec4 mutants (Novick, Schekman) first tied Rabs to secretion in the 1980s; RNAi and knockouts map each Rab to a trafficking step.

How Rabs Differ From Their Cousins — and Rab Conversion

Rabs share the G-domain fold and GTP/GDP switching with other small GTPases, but each family owns a different job:

• Ras — growth-signal relay at the plasma membrane, farnesylated (C15 lipid).
• Rho/Rac/Cdc42 — actin cytoskeleton and cell shape.
• Arf/Sar1 — vesicle coat recruitment (COPI, COPII, clathrin/AP adaptors); Arf uses a myristoyl switch, not a prenyl-GDI system.
• Ran — nucleocytoplasmic transport, using a nuclear/cytoplasmic GTP gradient.

Rabs are distinguished by their C-terminal geranylgeranylation, the GDI extraction cycle, and their role as compartment address labels. A signature phenomenon is Rab conversion during endosome maturation: active Rab5 recruits the Mon1-Ccz1 (SAND-1) complex, which displaces the Rab5 GEF Rabex-5 and acts as the GEF for Rab7. Rab7 then recruits a Rab5 GAP, extinguishing Rab5. The membrane's identity flips from early to late endosome — a cascade, not a gradual fade, showing how one Rab hands off to the next.

Why It Matters: Disease and Open Questions

Because Rabs route everything from hormones to pathogens, breaking the switch causes disease and offers a foothold for infection.

• Choroideremia: loss-of-function of REP-1 (CHM gene) leaves Rab27a under-prenylated in the retinal pigment epithelium, causing progressive X-linked blindness — a direct failure of the prenylation step that precedes the switch.
• Griscelli syndrome type 2: Rab27a mutations disrupt melanosome and lytic-granule transport, causing pigmentary and immune defects.
• Charcot-Marie-Tooth 2B: gain-of-function Rab7 mutations damage peripheral nerves.
• Pathogen hijacking: Salmonella's GtgE protease cleaves Rab32; Legionella injects effectors that AMPylate/phosphocholinate Rab1 to build a replicative vacuole.
• Cancer and neurodegeneration: Rab dysregulation alters receptor recycling, autophagy, and secretion; LRRK2 (Parkinson's) phosphorylates Rab8/Rab10 in their switch II region.

Open questions: how are ~60 Rabs each delivered to precisely the right membrane (the GDI/GDF targeting problem), how does the cell read combinatorial Rab codes, and can Rab-cycle enzymes be drugged selectively for cancer or infection?

Regulators of the Rab GTPase cycle and what each one does

Regulator	Action on Rab	Effect on the switch	Example
GEF (guanine nucleotide exchange factor)	Ejects tightly bound GDP so GTP (in ~10x molar excess in the cytosol) can bind	Turns switch ON	Rabex-5 for Rab5; Mon1-Ccz1 for Rab7
GAP (GTPase-activating protein)	Inserts an arginine/glutamine finger, accelerating GTP hydrolysis up to ~10^5-fold	Turns switch OFF	TBC-domain proteins (e.g., TBC1D15 for Rab7)
GDI (GDP dissociation inhibitor)	Caps the prenyl tail, extracts GDP-Rab from membrane, holds it soluble in cytosol	Keeps switch OFF and mobile	RabGDIalpha/beta (GDI1/GDI2)
REP + RabGGTase	Attach one or two C20 geranylgeranyl lipids to C-terminal cysteines	Enables membrane anchoring (prerequisite)	REP-1 (CHM) + geranylgeranyltransferase type II
GDF (GDI displacement factor)	Releases Rab from GDI at the correct target membrane	Licenses re-loading onto membrane	PRA1/Yip3 (proposed)